TABLE 3.

Antifungal susceptibilities of C. guilliermondii complex and C. albicans isolates from the CANDIPOP study^a

Antifungal	C. guilliermondii complex biofilm SMIC50 (μg/ml)			MIC (μg/ml)
				C. guilliermondii complex (n = 22)			C. albicans (n = 337)
	GM	MIC90	Range	GM	MIC90	Range	GM	MIC90	Range
Micafungin	8.28	≥512	0.25 to ≥512	0.27	1	0.25–4	0.03	0.031	0.031–1
Anidulafungin	2.46	232	0.062 to ≥512	1	2	0.5–1	0.03	0.031	0.031–0.25
Fluconazole	NT			5.27	16	0.5 to ≥64	0.21	0.25	≤0.125 to ≥64
Posaconazole	NT			0.08	0.5	0.031–1	0.015	0.015	≤0.015 to ≥8
Voriconazole	NT			0.10	0.5	≤0.015–2	0.016	0.015	≤0.015 to ≥8
Amphotericin B	NT			0.31	1	0.062–0.5	0.05	0.125	0.031–0.25

^aSee reference 3. SMIC₅₀, sessile MIC corresponding to 50% reduction of biofilm metabolic activity; GM, geometric mean; NT, not tested.